How To Invest In Septerna, Inc. Stock - SEPN Share Price Today & News | Stash

Invest in Septerna, Inc. on Stash

Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform.

To buy fractional shares of Septerna, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: SEPN

Septerna, Inc.

$33.40

-11.73%
(1W)

Jul ’26Jul ’26$32$35$38

1W1M1Y5Y

SEPN Performance Breakdown

Share Price

The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

$33.40

Today's change

This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.

5.83%

Year to date change (YTD)

This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).

19.37%

Dividend yield

Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.

0.0

Last dividend paid

The dollar value per share that was paid out to shareholders.

N/A

Last dividend pay date

The date shareholders were paid out for the last dividend issued.

N/A

About SEPN

Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

How to buy Septerna, Inc. stock on Stash

  1. Enter the amount you'd like to invest in Septerna, Inc. stock, then proceed to checkout.

  2. Set up your investment account in just a few minutes.

  3. Once you’ve finished your account, your Septerna, Inc. shares will be added to your new portfolio.

You can continue to build your portfolio by buying more stocks and funds—there are hundreds of options on Stash.

Disclaimer

Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.